• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清铁水平中度升高患者的保守治疗。

Conservative management of patients with moderately elevated serum iron levels.

作者信息

Bosse G M

机构信息

University of Louisville School of Medicine, Department of Emergency Medicine, KY 40292.

出版信息

J Toxicol Clin Toxicol. 1995;33(2):135-40. doi: 10.3109/15563659509000463.

DOI:10.3109/15563659509000463
PMID:7897752
Abstract

For the four year period 1990-1993, we retrospectively reviewed all cases of iron ingestion reported to a regional poison control center that had serum iron levels in the 300-500 micrograms/dL range and did not receive deferoxamine. A total of 32 patients did not undergo deferoxamine therapy or challenge testing. The mean age was 6.7 years (range five months to 21 years). The mean serum iron level was 372.8 micrograms/dL (range 301-487 micrograms/dL). Ten patients (31.3%) were asymptomatic. Symptoms included vomiting in 18 (56.3%), diarrhea in six (18.8%), lethargy in one (3.1%), and transient hypotension in one patient (3.1%). No patients presented with grossly bloody emesis or stool. Fifteen patients (46.9%) were hospitalized for at least one day. Seventeen (53.1%) were treated and released from the emergency department. All 32 patients recovered without sequelae. A conservative approach without deferoxamine therapy or challenge should be considered when serum iron levels are in the 300-500 micrograms/dL range in asymptomatic patients, as well as in those with self-limited, non-bloody emesis or diarrhea without other symptoms.

摘要

在1990年至1993年的四年期间,我们回顾性地研究了向一个地区毒物控制中心报告的所有铁摄入病例,这些病例的血清铁水平在300 - 500微克/分升范围内,且未接受去铁胺治疗。共有32例患者未接受去铁胺治疗或激发试验。平均年龄为6.7岁(范围为5个月至21岁)。平均血清铁水平为372.8微克/分升(范围为301 - 487微克/分升)。10例患者(31.3%)无症状。症状包括呕吐18例(56.3%)、腹泻6例(18.8%)、嗜睡1例(3.1%)和1例患者出现短暂低血压(3.1%)。没有患者出现明显的血性呕吐物或粪便。15例患者(46.9%)住院至少1天。17例(53.1%)在急诊科接受治疗后出院。所有32例患者均康复且无后遗症。对于无症状患者以及有自限性、非血性呕吐或腹泻且无其他症状的患者,当血清铁水平在300 - 500微克/分升范围内时,应考虑采用不进行去铁胺治疗或激发试验的保守方法。

相似文献

1
Conservative management of patients with moderately elevated serum iron levels.血清铁水平中度升高患者的保守治疗。
J Toxicol Clin Toxicol. 1995;33(2):135-40. doi: 10.3109/15563659509000463.
2
Assessment of management guidelines. Acute iron ingestion.管理指南评估。急性铁摄入。
Clin Pediatr (Phila). 1990 Jun;29(6):316-21. doi: 10.1177/000992289002900604.
3
Leukocytosis, hyperglycemia, vomiting, and positive X-rays are not indicators of severity of iron overdose in adults.白细胞增多、血糖升高、呕吐和X线检查呈阳性并非成人铁过量严重程度的指标。
Am J Emerg Med. 1996 Sep;14(5):454-5. doi: 10.1016/S0735-6757(96)90149-7.
4
Assessment of acute iron poisoning by laboratory and clinical observations.
Am J Emerg Med. 1993 Mar;11(2):99-103. doi: 10.1016/0735-6757(93)90099-w.
5
Severe iron poisoning treated with enteral and intravenous deferoxamine.
Ann Emerg Med. 1983 May;12(5):306-9. doi: 10.1016/s0196-0644(83)80515-0.
6
Benefits of parenteral deferoxamine for acute iron poisoning.胃肠外去铁胺治疗急性铁中毒的益处。
J Toxicol Clin Toxicol. 1996;34(5):485-9. doi: 10.3109/15563659609028005.
7
Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine.用去铁胺间歇输注治疗严重铁中毒后的生存情况。
J Toxicol Clin Toxicol. 1995;33(1):61-6. doi: 10.3109/15563659509020217.
8
Management of acute iron overdose.急性铁过量的管理。
Clin Pharm. 1989 Jun;8(6):428-40.
9
Acute iron poisoning.
Pediatr Ann. 1996 Jan;25(1):33-8. doi: 10.3928/0090-4481-19960101-08.
10
Multi-center retrospective evaluation of carbonyl iron ingestions.羰基铁摄入的多中心回顾性评估。
Vet Hum Toxicol. 2002 Feb;44(1):28-9.